In today’s oncology landscape, the pace of change is staggering. Clinical trials, FDA approvals, and updated guidelines happen constantly. Yet many oncologists are still relying on resources that are static or quickly outdated.
Dr. Saro Sarkisian, a practicing medical oncologist, knows this challenge firsthand.
In this short video, he explains the frustration clinicians face when trying to make time-sensitive treatment decisions using tools that haven’t kept pace with the data. Traditional references like UpToDate can offer an overview, but in oncology, “up to date” isn’t always current enough.
That’s why Oncoscope-AI is a game changer.
Oncoscope-AI is a hybrid decision-support platform built specifically for oncologists. It combines the speed and reach of AI with the critical oversight of expert human reviewers. The result? Evidence-based treatment intelligence that’s updated daily, organized by patient profile, and ready to use in clinical decision-making.
As Dr. Sarkisian puts it:
“We need tools that reflect how fast oncology is evolving, something that doesn’t just tell us what was true last year, but what’s happening now.”
If you’re an oncologist navigating today’s complex treatment environment, real-time data isn’t a luxury, it’s a necessity.
Beka Vinogradov is the Digital Communications Lead for Oncoscope-AI. She holds a Master’s in Health Administration and has extensive experience and education in business, marketing, and design.
